These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 34526990)

  • 1. Harnessing Treg Homeostasis to Optimize Posttransplant Immunity: Current Concepts and Future Perspectives.
    Ikegawa S; Matsuoka KI
    Front Immunol; 2021; 12():713358. PubMed ID: 34526990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose interleukin-2 as a modulator of Treg homeostasis after HSCT: current understanding and future perspectives.
    Matsuoka KI
    Int J Hematol; 2018 Feb; 107(2):130-137. PubMed ID: 29234980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.
    Matsuoka K; Kim HT; McDonough S; Bascug G; Warshauer B; Koreth J; Cutler C; Ho VT; Alyea EP; Antin JH; Soiffer RJ; Ritz J
    J Clin Invest; 2010 May; 120(5):1479-93. PubMed ID: 20389017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses of regulatory and effector T-cells to low-dose interleukin-2 differ depending on the immune environment after allogeneic stem cell transplantation.
    Meguri Y; Asano T; Yoshioka T; Iwamoto M; Ikegawa S; Sugiura H; Kishi Y; Nakamura M; Sando Y; Kondo T; Sumii Y; Maeda Y; Matsuoka KI
    Front Immunol; 2022; 13():891925. PubMed ID: 35983059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
    Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
    Front Immunol; 2018; 9():3104. PubMed ID: 30733722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of Th17, Tc17 and Treg cells after paediatric haematopoietic stem cell transplantation: Impact of interleukin-7.
    Kielsen K; Ryder LP; Lennox-Hvenekilde D; Gad M; Nielsen CH; Heilmann C; Ifversen M; Pedersen AE; Müller K
    Immunobiology; 2018 Feb; 223(2):220-226. PubMed ID: 29033080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of peri-SCT immune modulation on Treg homeostasis and GVHD].
    Matsuoka KI
    Rinsho Ketsueki; 2018; 59(8):1095-1100. PubMed ID: 30185711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges.
    Hefazi M; Bolivar-Wagers S; Blazar BR
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease.
    Matsuoka K; Koreth J; Kim HT; Bascug G; McDonough S; Kawano Y; Murase K; Cutler C; Ho VT; Alyea EP; Armand P; Blazar BR; Antin JH; Soiffer RJ; Ritz J
    Sci Transl Med; 2013 Apr; 5(179):179ra43. PubMed ID: 23552371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.
    Kennedy-Nasser AA; Ku S; Castillo-Caro P; Hazrat Y; Wu MF; Liu H; Melenhorst J; Barrett AJ; Ito S; Foster A; Savoldo B; Yvon E; Carrum G; Ramos CA; Krance RA; Leung K; Heslop HE; Brenner MK; Bollard CM
    Clin Cancer Res; 2014 Apr; 20(8):2215-25. PubMed ID: 24573552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior immune reconstitution using Treg-expanded donor cells versus PTCy treatment in preclinical HSCT models.
    Wolf D; Bader CS; Barreras H; Copsel S; Pfeiffer BJ; Lightbourn CO; Altman NH; Komanduri KV; Levy RB
    JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.
    Bremm M; Huenecke S; Lehrnbecher T; Ponstingl E; Mueller R; Heinze A; Bug G; Quaiser A; Kapinsky M; Brehm C; Bader P; Schneider G; Klingebiel T; Koehl U
    J Immunol Methods; 2011 Oct; 373(1-2):36-44. PubMed ID: 21839739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of donor CD4+CD25+ regulatory T cells on hematopoietic and immune reconstitution, GVHD and disease-free survival after allogeneic hematopoietic stem cell transplantation].
    Yang K; Fan ZP; Liu QF; Zhang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):537-41. PubMed ID: 18495584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparameter single-cell profiling of human CD4+FOXP3+ regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease.
    Dong S; Maiella S; Xhaard A; Pang Y; Wenandy L; Larghero J; Becavin C; Benecke A; Bianchi E; Socié G; Rogge L
    Blood; 2013 Sep; 122(10):1802-12. PubMed ID: 23818545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of naturally arising regulatory T cells in hematopoietic cell transplantation.
    Nguyen VH; Zeiser R; Negrin RS
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):995-1009. PubMed ID: 17084366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of regulatory T cells in graft-versus-host disease management.
    Whangbo JS; Antin JH; Koreth J
    Expert Rev Hematol; 2020 Feb; 13(2):141-154. PubMed ID: 31874061
    [No Abstract]   [Full Text] [Related]  

  • 17. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
    Wolf D; Barreras H; Bader CS; Copsel S; Lightbourn CO; Pfeiffer BJ; Altman NH; Podack ER; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2017 May; 23(5):757-766. PubMed ID: 28219835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD4+CD25+highFoxp3+CD62L+ regulatory T cells and invariant NKT cells in human allogeneic hematopoietic stem cell transplantation.
    Vela-Ojeda J; Montiel-Cervantes L; Granados-Lara P; Reyes-Maldonado E; García-Latorre E; Garcia-Chavez J; Majluf-Cruz A; Mayani H; Borbolla-Escoboza JR; Esparza MG
    Stem Cells Dev; 2010 Mar; 19(3):333-40. PubMed ID: 19919293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease.
    Hippen KL; Hefazi M; Larson JH; Blazar BR
    Front Immunol; 2022; 13():926550. PubMed ID: 35967386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation.
    Locke FL; Pidala J; Storer B; Martin PJ; Pulsipher MA; Chauncey TR; Jacobsen N; Kröger N; Walker I; Light S; Shaw BE; Beato F; Laport GG; Nademanee A; Keating A; Socie G; Anasetti C
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):405-411. PubMed ID: 28007665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.